ACLASTA/ZOLEDRONATE Adverse Event: Breast cancer recurrent
ACLASTA/ZOLEDRONATE Adverse Event: Breast cancer recurrent is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: ACLASTA/ZOLEDRONATE; Product category: Drug; Primary reaction: Breast cancer recurrent.
| Primary drug | ACLASTA/ZOLEDRONATE |
|---|---|
| Product category | Drug |
| Primary reaction | Breast cancer recurrent |
| All reactions | Breast cancer recurrent; Metastases to bone; Pathological fracture; Rib fracture |
| Seriousness | Serious |
| Patient outcome | Not Recovered/Not Resolved |
| Patient sex | Female |
| All drugs reported | ACLASTA/ZOLEDRONATE; ADARTREL |
| Reporter country | FR |
| Reporter type | 1 |
| Report date | 20140312 |
| Report ID | 10004903 |
$299/mo
Try FDATracker →